GlobeNewswire Inc | Jul 23, 2021 03:26PM EDT

July 23, 2021

NEW YORK, July 23, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire P.C. announcesthe proposed settlement of the derivative action captioned In re Vanda Pharmaceuticals Inc. Derivative Litigation, Case No. 1:19-cv-04293-FB-LB in the United States District Court for the Eastern District of New York.

If you were a stockholder of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) as of July 19, 2021 and continue to own such shares, please click HERE to read the Notice to Current Vanda Stockholders, which contains important information regarding your rights.

Please reach out to counsel for Plaintiffs with any questions or concerns at:

Counsel for Plaintiffs:Gregory M. NespoleDaniel TepperLEVI & KORSINSKY, LLP55 Broadway, 10th FloorNew York NY 10006Fax: (212) 363-7171

W. Scott Holleman Garam ChoeBRAGAR EAGEL & SQUIRE, P.C.810 Seventh Avenue, Suite 620New York, NY 10019Fax: (212) 486-0462